Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Restructuring Costs (2024 - 2025)

Traws Pharma's Restructuring Costs history spans 2 years, with the latest figure at $889000.0 for Q4 2025.

  • Quarterly results put Restructuring Costs at $889000.0 for Q4 2025, down 8.35% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (down 29.66% YoY), and the annual figure for FY2025 was $2.6 million, down 21.48%.
  • Restructuring Costs for Q4 2025 was $889000.0 at Traws Pharma, up from $499000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $2.6 million in Q1 2024 to a low of $499000.0 in Q3 2025.